|
FDA Acknowledges Corrections, Sends Optovue Warning Letter
Although Optovue is taking corrective action to bring a normative database used with its RTVue optical coherence tomography into compliance, it received a warning letter that notes the effectiveness of the corrections can’t be fully reviewed and evaluated because they are ongoing.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives